SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PLC's 'Heart Laser'
PLC 30.130.0%Dec 14 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: kenny who wrote (31)7/1/1997 9:53:00 AM
From: John Martin   of 47
 
Two reasons for the loss.
1) Medicare started paying for the procedure last year during the trials. Early this year they stopped siting that they would not pay for non-FDA approved procedures. Hence the added expense.

2) PLC has two methods of selling their machines. One is an outright sale which most of the machines last year were (7+ to Japan). The second method is through placement. They will do this with customers with good credit. They put the machine in place on a multi-year contract. PLC gets paid x amount per procedure and there is a contractual obligation for x procedures/month. PLC will make much more on placement but has to consume the cost of the equipment in the first year. I don't know if this is something that they will depreciate over x years?

These sales methods are covered completely in their 10Q or Annual report.

HTH,

John
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext